Literature DB >> 6230062

Long-term observations on a crimped Dacron aortic bypass graft in the growing child.

F Robicsek, H K Daugherty, P Vajtai.   

Abstract

Nineteen years of clinical and angiographic observations are presented on a patient with congenital stricture of the upper abdominal aorta who underwent thoracic-to-abdominal aorta bypass grafting using a woven crimped Dacron vascular prosthesis. These observations indicate that if such a prosthesis is properly applied, i.e., attached in a proper angle and is not stretched as it is usually done in the adult, then it will be capable of gradual "lengthening" through the years and thus adapt to the needs of a growing child.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6230062      PMCID: PMC1353340          DOI: 10.1097/00000658-198402000-00019

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  5 in total

1.  FACTORS CONTRIBUTING TO LONG-TERM FAILURES IN HUMAN VASCULAR PROSTHETIC GRAFTS.

Authors:  S A WESOLOWSKI; C C FRIES; G HENNIGAR; L M FOX; P N SAWYER; L R SAUVAGE
Journal:  J Cardiovasc Surg (Torino)       Date:  1964 Nov-Dec       Impact factor: 1.888

2.  COARCTATION OF THE ABDOMINAL AORTA DIAGNOSED BY AORTOGRAPHY: REPORT OF THREE CASES.

Authors:  F ROBICSEK; P W SANGER; H K DAUGHERTY
Journal:  Ann Surg       Date:  1965-08       Impact factor: 12.969

3.  Failure of ultralightweight knitted Dacron grafts in arterial reconstruction.

Authors:  L W Ottinger; R C Darling; L S Wirthlin; R R Linton
Journal:  Arch Surg       Date:  1976-02

4.  Dacron aortic graft failure.

Authors:  P A Cooke; P A Nobis; R J Stoney
Journal:  Arch Surg       Date:  1974-01

5.  Multiple aneurysms in dacron velour graft.

Authors:  J May; M Stephen
Journal:  Arch Surg       Date:  1978-03
  5 in total
  1 in total

1.  Aortic bypass surgery using synthetic conduits in a child with mycotic aneurysmal disease.

Authors:  A Sayed; M Mashaal; S A Soliman; H Elwan
Journal:  Ann R Coll Surg Engl       Date:  2016-04       Impact factor: 1.891

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.